XTAE
THES
Market cap44mUSD
Jul 10, Last price
486.90ILS
1D
-7.47%
1Q
-44.73%
Name
Thirdeye Systems Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Thirdeye Systems Ltd. specializes in the advanced research and development of sophisticated object recognition algorithms, with a particular focus on the thermal spectrum. The company provides its state-of-the-art solutions to the Israel Defense Forces and other defense contractors. Its product portfolio includes Chimera, a compact and lightweight day-and-night system that combines an uncooled Long-Wave Infrared (LWIR) thermal imager with an HD electro-optical (EO) camera. For aerial threat detection, Meduza offers an electro-optical scanning system designed for drone recognition, while Meduza-S acts as an optical radar to significantly enhance the accuracy of anti-drone defenses. Tesseract provides an upgrade solution, transforming passive observation devices into sophisticated payloads capable of detecting, recognizing, and tracking drones. Further offerings include GoIR, a adaptable thermal imaging solution engineered for extreme outdoor conditions, delivering superior thermal image quality. aEYE C2 features cutting-edge AI algorithms for detection and classification. Additionally, aEYE enables drones to conduct fully autonomous patrolling operations, from launch to precise landing, utilizing cloud-based AI for human detection with the integrated Chimera payload. Thirdeye Systems' innovations are deployed across various critical sectors, including autonomous vehicles, maritime security, protection of vital assets, counter-terrorism efforts, border control, search and rescue missions, and airport security, serving clients both domestically in Israel and globally. Incorporated in 1979, the company was previously known as New Horizon Group Ltd. before rebranding to Thirdeye Systems Ltd. in May 2021, and its operations are based in Netanya, Israel.
Valuation
Title ILS in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||